메뉴 건너뛰기




Volumn 5, Issue 1, 2014, Pages 185-195

The proto-oncogene KRAS is targeted by miR-200c

Author keywords

Breast cancer; Cell cycle; K ras; Lung cancer; MiRNA; Proliferation

Indexed keywords

DOXORUBICIN; K RAS PROTEIN; MESSENGER RNA; MICRORNA 200C; SMALL INTERFERING RNA; MICRORNA; MIRN200 MICRORNA, HUMAN;

EID: 84893819262     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1427     Document Type: Article
Times cited : (68)

References (56)
  • 1
    • 1242340431 scopus 로고    scopus 로고
    • Oncogenic Ras and its role in tumor cell invasion and metastasis
    • Campbell PM and Der CJ. Oncogenic Ras and its role in tumor cell invasion and metastasis. Seminars in cancer biology. 2004; 14(2):105-114.
    • (2004) Seminars in cancer biology. , vol.14 , Issue.2 , pp. 105-114
    • Campbell, P.M.1    Der, C.J.2
  • 3
    • 84862571677 scopus 로고    scopus 로고
    • Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer
    • Califano R, Landi L and Cappuzzo F. Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer. Drugs. 2012; 72 Suppl 1:28-36.
    • (2012) Drugs , vol.72 , Issue.SUPPL. 1 , pp. 28-36
    • Califano, R.1    Landi, L.2    Cappuzzo, F.3
  • 4
    • 78650026316 scopus 로고    scopus 로고
    • KRAS and BRAF: drug targets and predictive biomarkers
    • Vakiani E and Solit DB. KRAS and BRAF: drug targets and predictive biomarkers. The Journal of pathology. 2011; 223(2):219-229.
    • (2011) The Journal of pathology. , vol.223 , Issue.2 , pp. 219-229
    • Vakiani, E.1    Solit, D.B.2
  • 5
    • 77956268839 scopus 로고    scopus 로고
    • Understanding resistance to EGFR inhibitors-impact on future treatment strategies
    • Wheeler DL, Dunn EF and Harari PM. Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nature reviews Clinical oncology. 2010; 7(9):493-507.
    • (2010) Nature reviews Clinical oncology. , vol.7 , Issue.9 , pp. 493-507
    • Wheeler, D.L.1    Dunn, E.F.2    Harari, P.M.3
  • 7
    • 33750370444 scopus 로고    scopus 로고
    • MicroRNA signatures in human cancers
    • Calin GA and Croce CM. MicroRNA signatures in human cancers. Nature reviews Cancer. 2006; 6(11):857-866.
    • (2006) Nature reviews Cancer. , vol.6 , Issue.11 , pp. 857-866
    • Calin, G.A.1    Croce, C.M.2
  • 8
  • 9
    • 33749507943 scopus 로고    scopus 로고
    • A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
    • Kent OA and Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 2006; 25(46):6188-6196.
    • (2006) Oncogene. , vol.25 , Issue.46 , pp. 6188-6196
    • Kent, O.A.1    Mendell, J.T.2
  • 16
    • 84883143101 scopus 로고    scopus 로고
    • Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis
    • To MD, Rosario RD, Westcott PM, Banta KL and Balmain A. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. Oncogene. 2012.
    • (2012) Oncogene
    • To, M.D.1    Rosario, R.D.2    Westcott, P.M.3    Banta, K.L.4    Balmain, A.5
  • 19
    • 34548565806 scopus 로고    scopus 로고
    • Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
    • Hurteau GJ, Carlson JA, Spivack SD and Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer research. 2007; 67(17):7972-7976.
    • (2007) Cancer research. , vol.67 , Issue.17 , pp. 7972-7976
    • Hurteau, G.J.1    Carlson, J.A.2    Spivack, S.D.3    Brock, G.J.4
  • 20
    • 47249091921 scopus 로고    scopus 로고
    • The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
    • Korpal M, Lee ES, Hu G and Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. The Journal of biological chemistry. 2008; 283(22):14910-14914.
    • (2008) The Journal of biological chemistry. , vol.283 , Issue.22 , pp. 14910-14914
    • Korpal, M.1    Lee, E.S.2    Hu, G.3    Kang, Y.4
  • 21
    • 44649163918 scopus 로고    scopus 로고
    • A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
    • Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S and Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO reports. 2008; 9(6):582-589.
    • (2008) EMBO reports. , vol.9 , Issue.6 , pp. 582-589
    • Burk, U.1    Schubert, J.2    Wellner, U.3    Schmalhofer, O.4    Vincan, E.5    Spaderna, S.6    Brabletz, T.7
  • 23
    • 79955102595 scopus 로고    scopus 로고
    • Targets of miR-200c mediate suppression of cell motility and anoikis resistance
    • Howe EN, Cochrane DR and Richer JK. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast cancer research: BCR. 2011; 13(2):R45.
    • (2011) Breast cancer research: BCR. , vol.13 , Issue.2
    • Howe, E.N.1    Cochrane, D.R.2    Richer, J.K.3
  • 26
    • 77956547097 scopus 로고    scopus 로고
    • Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells
    • Iliopoulos D, Lindahl-Allen M, Polytarchou C, Hirsch HA, Tsichlis PN and Struhl K. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Molecular cell. 2010; 39(5):761-772.
    • (2010) Molecular cell. , vol.39 , Issue.5 , pp. 761-772
    • Iliopoulos, D.1    Lindahl-Allen, M.2    Polytarchou, C.3    Hirsch, H.A.4    Tsichlis, P.N.5    Struhl, K.6
  • 29
    • 84855359334 scopus 로고    scopus 로고
    • A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
    • Bryant JL, Britson J, Balko JM, Willian M, Timmons R, Frolov A and Black EP. A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT. British journal of cancer. 2012; 106(1):148-156.
    • (2012) British journal of cancer. , vol.106 , Issue.1 , pp. 148-156
    • Bryant, J.L.1    Britson, J.2    Balko, J.M.3    Willian, M.4    Timmons, R.5    Frolov, A.6    Black, E.P.7
  • 30
    • 77954863985 scopus 로고    scopus 로고
    • Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
    • Cochrane DR, Howe EN, Spoelstra NS and Richer JK. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. Journal of oncology. 2010; 2010:821717.
    • (2010) Journal of oncology. , vol.2010 , pp. 821717
    • Cochrane, D.R.1    Howe, E.N.2    Spoelstra, N.S.3    Richer, J.K.4
  • 31
    • 66849140943 scopus 로고    scopus 로고
    • MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
    • Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK and Richer JK. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Molecular cancer therapeutics. 2009; 8(5):1055-1066.
    • (2009) Molecular cancer therapeutics. , vol.8 , Issue.5 , pp. 1055-1066
    • Cochrane, D.R.1    Spoelstra, N.S.2    Howe, E.N.3    Nordeen, S.K.4    Richer, J.K.5
  • 32
    • 84870549360 scopus 로고    scopus 로고
    • miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression
    • Kopp F, Oak PS, Wagner E and Roidl A. miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. PloS one. 2012; 7(11):e50469.
    • (2012) PloS one , vol.7 , Issue.11
    • Kopp, F.1    Oak, P.S.2    Wagner, E.3    Roidl, A.4
  • 33
    • 77951248184 scopus 로고    scopus 로고
    • E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells
    • Tryndyak VP, Beland FA and Pogribny IP. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. International journal of cancer Journal international du cancer. 2010; 126(11):2575-2583.
    • (2010) International journal of cancer Journal international du cancer. , vol.126 , Issue.11 , pp. 2575-2583
    • Tryndyak, V.P.1    Beland, F.A.2    Pogribny, I.P.3
  • 40
    • 0023651180 scopus 로고
    • The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231
    • Kozma SC, Bogaard ME, Buser K, Saurer SM, Bos JL, Groner B and Hynes NE. The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. Nucleic acids research. 1987; 15(15):5963-5971.
    • (1987) Nucleic acids research. , vol.15 , Issue.15 , pp. 5963-5971
    • Kozma, S.C.1    Bogaard, M.E.2    Buser, K.3    Saurer, S.M.4    Bos, J.L.5    Groner, B.6    Hynes, N.E.7
  • 43
    • 64049102720 scopus 로고    scopus 로고
    • Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9
    • Wang XQ, Li H, Van Putten V, Winn RA, Heasley LE and Nemenoff RA. Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9. Molecular biology of the cell. 2009; 20(3):791-800.
    • (2009) Molecular biology of the cell. , vol.20 , Issue.3 , pp. 791-800
    • Wang, X.Q.1    Li, H.2    Van Putten, V.3    Winn, R.A.4    Heasley, L.E.5    Nemenoff, R.A.6
  • 44
    • 4143146567 scopus 로고    scopus 로고
    • Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells
    • Agbunag C and Bar-Sagi D. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Cancer research. 2004; 64(16):5659-5663.
    • (2004) Cancer research. , vol.64 , Issue.16 , pp. 5659-5663
    • Agbunag, C.1    Bar-Sagi, D.2
  • 45
    • 0030996978 scopus 로고    scopus 로고
    • K-ras modulates the cell cycle via both positive and negative regulatory pathways
    • Fan J and Bertino JR. K-ras modulates the cell cycle via both positive and negative regulatory pathways. Oncogene. 1997; 14(21):2595-2607.
    • (1997) Oncogene. , vol.14 , Issue.21 , pp. 2595-2607
    • Fan, J.1    Bertino, J.R.2
  • 47
    • 0022622668 scopus 로고
    • Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene
    • Valenzuela DM and Groffen J. Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene. Nucleic acids research. 1986; 14(2):843-852.
    • (1986) Nucleic acids research. , vol.14 , Issue.2 , pp. 843-852
    • Valenzuela, D.M.1    Groffen, J.2
  • 49
    • 77955172153 scopus 로고    scopus 로고
    • miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer
    • Uhlmann S, Zhang JD, Schwager A, Mannsperger H, Riazalhosseini Y, Burmester S, Ward A, Korf U, Wiemann S and Sahin O. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene. 2010; 29(30):4297-4306.
    • (2010) Oncogene , vol.29 , Issue.30 , pp. 4297-4306
    • Uhlmann, S.1    Zhang, J.D.2    Schwager, A.3    Mannsperger, H.4    Riazalhosseini, Y.5    Burmester, S.6    Ward, A.7    Korf, U.8    Wiemann, S.9    Sahin, O.10
  • 51
    • 84860214990 scopus 로고    scopus 로고
    • Intra-tumour heterogeneity: a looking glass for cancer?
    • Marusyk A, Almendro V and Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nature reviews Cancer. 2012; 12(5):323-334.
    • (2012) Nature reviews Cancer. , vol.12 , Issue.5 , pp. 323-334
    • Marusyk, A.1    Almendro, V.2    Polyak, K.3
  • 54
    • 71249151558 scopus 로고    scopus 로고
    • Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery
    • Philipp A, Zhao X, Tarcha P, Wagner E and Zintchenko A. Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery. Bioconjugate chemistry. 2009; 20(11):2055-2061.
    • (2009) Bioconjugate chemistry. , vol.20 , Issue.11 , pp. 2055-2061
    • Philipp, A.1    Zhao, X.2    Tarcha, P.3    Wagner, E.4    Zintchenko, A.5
  • 55
    • 0041935939 scopus 로고    scopus 로고
    • ImageJ
    • U.S. National Institutes of Health, Bethesda, Maryland, USA
    • Rasband WS. (1997-2008). ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA.
    • (1997)
    • Rasband, W.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.